Background: Acute and transient psychotic disorders (ATPDs) constitute a highly heterogeneous category of brief psychotic disorders. The long-term course and outcomes of ATPDs is not completely clear, with more than half of patients initially diagnosed with ATPDs shifting towards other psychotic spectrum diagnoses. Uncertainties in the real-world clinical care of these patients is further complicated by the diagnostic overlap with the Brief Limited Intermittent Psychotic Symptoms (BLIPS). Thus, patients with similar diagnostic features may either be recommended conventional antipsychotic treatment (if diagnosed with ATPD and according to the current guidelines for first episode psychosis -FEP) or be contraindicated antipsychotic treatment and receive psychological therapies (recommended for BLIPS cases). Given the complexity of the clinical presentation, admission to highly specialized services for early intervention in psychotic disorders (EIP) should represent the best therapeutic pathway for these patients. However, it is not known how many individuals with ATPDs are effectively detected and treated by EIP services. This study aims at overcoming such a gap in knowledge by describing the pathways to care of patients with ATPDs and the treatments received across eight follow-up time-points (3, 6, 12, 18, 24, 48, 72, and 96 months). Methods: Electronic health record-based retrospective cohort study including all patients who received a first index diagnosis of ATPD (F23, ICD-10) within the South London and Maudsley (SLaM) National Health Service Trust, between 1st April 2006 and 15th June 2017. Sociodemographic and clinical characteristics were analyzed using one-way ANOVA and Tukey post-hoc tests for continuous variables and chi square test for categorical variables. Logistic regression analyses were used to investigate the association between sociodemographic characteristics and detection/treatment by EIP. Results: A total of 3074 patients receiving a first index diagnosis of ATPD (F23, ICD-10) within SLaM were included. The mean follow-up was 1495 days. After 8-year, 1883 cases (61.26%) retained the index diagnosis of ATPD; the remaining developed schizophrenia (23.8%), affective-spectrum psychoses (4.8%), and other psychotic disorders. Only 7.5 % of ATPDs was detected and treated by Early intervention in Psychosis services (EIP). The remaining quote of patients were treated with general mental health services (91.5%). Active treatment by EIS was more common among males, caucasian, and younger individuals (odds ratio (OR) = 1.35, 95% CI 1.01-1.7, P<0.001; OR = 0.6, 95% CI 0. P<0.001; and OR = 0.91, P<0.001, respectively). Almost half of the total sample (48.5%) was in treatment with antipsychotic medications after 1 year of follow-up. This proportion dropped to 25% after 3 years of active treatment. Less than 1% of ATPDs were offered psychotherapy interventions at any of the 8 time points of interest. Discussion: The present study shows that the largest majority of individuals with ATPD (91.5%) is never detected and treated by the EIP services, which should be the best clinical option for these patients. This suggests that they are receiving neither the best first-episode care nor the best preventative care. Efforts should be done to promote outreach campaigns in general mental health services to persuade clinicians referring these patients to local EIP services, with the aim of providing the best possible care.
T123. PERSISTENT NEGATIVE SYMPTOMS IN FIRST EPISODE PSYCHOSIS: PREVALENCE, PREDICTORS AND PROGNOSIS
Stephen Austin* Background: Negative symptoms are a core component of schizophrenia. These symptoms have been shown to impact on a range of outcomes, and often are resistant to pharmacological and psychosocial interventions treatment. The goal of this study was to investigate the prevalence, baseline predictors and long-term impact of persistent negative symptoms (PNS) within a large representative cohort of people with first episode psychosis. Methods: The study had prospective design. Patients recruited into the OPUS trial (1998) (1999) (2000) with a first time diagnosis within the schizophrenia spectrum (F20-28) were included. People were classified with persistent negative symptoms, if they experienced enduring negative symptoms that were not secondary to psychotic symptoms, depression or due to medication side effects. Clinical data collected at baseline, 1 year, 2 years and 10 years was used to identify predictors of PNS and long-term outcomes. Results: Full clinical data was available on 369 people. A total of 90 people (24%) displayed PNS, two years after diagnosis. Significant univariable predictors of PNS at baseline were low functioning, male sex, cannabis use, poor pre-morbid social functioning and high levels of negative symptoms. People that displayed PNS had significantly lower functioning and higher levels of psychopathology at 10 year follow-up. A total 3% of people with PNS were recovered at 10 year follow-up compared to rate of 20% recovered without PNS (OR 7.42, p<0.01). Discussion: A significant proportion of the cohort displayed persistent negative symptoms and these symptoms significantly impacted on long-term outcomes. Researchers and clinicians need to continue to develop effective interventions that can ameliorate these symptoms and potentially impact on illness prognosis within schizophrenia. Background: Schizophrenia is a highly heritable disease; yet heritability rate could never exceed 80% in most studies. Genetic factors could never then, by their own, account for the whole risk for developing schizophrenia. Thus, environmental factors co-play a major role. Urbanity is now well established to be one of the most influential environmental factors for developing severe mental illnesses. A strong association between exposure to urban environment and the risk of developing schizophrenia, was demonstrated and several studies have shown that living in an urban environment increases the risk for developing schizophrenia. The aim of this study was to examine the clinic biological characteristics of patients with schizophrenia according to their rural or urban condition. Methods: This study was based on 106 patients with a DSM 5 diagnosis of schizophrenia in period of remission. Sociodemographic and clinical characteristics were assessed. PANSS scale, Calgary depression scale, CGI scale were used to assess different features of the disease and biological variables (CBC, renal and liver markers, inflammatory markers: CRP and CRP hs) were evaluated. Two groups were formed according to the patient's urban or rural birth and early living. Results: There were 71 urban and 35 rural patients. The mean age was 42,7 years in the urban group and 42,3 years in the rural group. Socio demographic characteristics were similar between the two groups. Patients with urban background had a higher score on the negative subscale (p=0,01) and the general psychopathology subscale (P=0,025) of the PANSS compared with rural patients. Otherwise, compared to patients with a rural
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